Chemokine Receptor CCR5 Antagonist Maraviroc: Medicinal Chemistry and Clinical Applications

Current Topics in Medicinal Chemistry - United Arab Emirates
doi 10.2174/1568026614666140827143745
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bentham Science Publishers Ltd.

Related search

Chemokine Receptor CCR5: From AIDS to Atherosclerosis

British Journal of Pharmacology
Pharmacology
2011English

Novel Alleles of the Chemokine-Receptor Gene CCR5

American Journal of Human Genetics
Genetics
1997English

Intragenus (Homo) Variation in a Chemokine Receptor Gene (CCR5)

PLoS ONE
Multidisciplinary
2018English

Efficacy of the CCR5 Antagonist Maraviroc in Reducing Early, Ritonavir-Induced Atherogenesis and Advanced Plaque Progression in Mice

Circulation
Cardiovascular MedicinePhysiologyCardiology
2013English

Incorporation of Fluorescently Tagged Chemokine Receptor 5 (CCR5) Into Membrane Nanoparticles

Biophysical Journal
Biophysics
2013English

A Topical Microbicide Gel Formulation of CCR5 Antagonist Maraviroc Prevents HIV-1 Vaginal Transmission in Humanized RAG-hu Mice

PLoS ONE
Multidisciplinary
2011English

Annulus Fibrosus Cells Express and Utilize C-C Chemokine Receptor 5 (CCR5) for Migration

Spine Journal
SurgeryOrthopedicsSports MedicineNeurology
2017English

Applications of Cucurbiturils in Medicinal Chemistry and Chemical Biology

Frontiers in Chemistry
Chemistry
2019English

3D Printing in Medicinal Chemistry: Applications, Prospective and Consideration

2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy